Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease

LDp/CDp is a new treatment option for advanced PD (aPD). Treatment success depends on education, selecting appropriate patients, setting patient expectations, implementing individualized dosing strategies, and managing adverse effects.

Authors

Institutions

Publication Details

Journal
Movement Disorders Clinical Practice
Published
2026-01-16
DOI
https://doi.org/10.1002/mdc3.70489
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease

Giulia Lazzeri, Drew S. Kern, Tobias Warnecke, Yuval Ramot et al.
Movement Disorders Clinical Practice
Parkinson's Disease Mechanisms and Treatments
article

Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease

Giulia Lazzeri, Drew S. Kern, Tobias Warnecke, Yuval Ramot, Mag Klaus Seppi, Eric Freire-Álvarez, Manan Shah, Pedro Mendes‐Bastos, Pavnit Kukreja, Per Odin, Robert Wiggins, K. Ray Chaudhuri, Stuart H. Isaacson, Lucie Hopes, Bruno Bergmans, Rajesh Pahwa, Karolina Poplawska‐Domaszewicz, Noriko Nishikawa, Bjoern Fritz, Koray Onuk, Robert S. Kirsner
article en

Abstract

LDp/CDp is a new treatment option for advanced PD (aPD). Treatment success depends on education, selecting appropriate patients, setting patient expectations, implementing individualized dosing strategies, and managing adverse effects.

Movement Disorders Clinical Practice
Poznan University of Medical Sciences (PL), King's College - North Carolina (US), Lund University (SE), Florida International University (US), Hebrew University of Jerusalem (IL), Hadassah Medical Center (IL), Ghent University Hospital (BE), Dubai Hospital (AE), AbbVie (United States) (US), Juntendo University (JP), Centre Hospitalier Régional et Universitaire de Nancy (FR), Istituto Ortopedico Gaetano Pini (IT), Hospital General Universitario de Elche (ES), University of Miami Hospital (US), AZ Sint-Jan (BE), UK Dementia Research Institute (GB), Parkinson's Research and Education Foundation (US), Novant Health Presbyterian Medical Center (US), Klinikum Osnabrück (DE), King's College Hospital (GB), University Hospital Innsbruck (AT), Hospital do Desterro (PT), Parkinson's Foundation (US), University of Colorado Denver (US)
Openalex Percentile: Top 86%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.